Home

CVI Investments reported a 4.9% stake in Silexion Therapeutics SLXN · 456,531 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4.9%
Last report
8.5% · filed 25/01/23
Shares held
456,531 sh
Class
Ordinary Shares, par value $0.0009 per share
Event date
25/03/31
Filed
25/05/12

4.9% stake · below 5%

Stake
4.9%
Last report
8.5%
Since last report
−3.6pp

Silexion Therapeutics trades, last 26 weeks

What else happened in Silexion Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

CVI Investments's other 5% stake reports

  • CVI Investments

    5% stakeOutlook Therapeutics

    9.9% stake

    Filed 08/19

  • CVI Investments

    5% stakeNewbridge Acquisition

    4.9% stake

    Filed 08/14

  • CVI Investments

    5% stakeHigh-Trend International Group

    0% stake

    Filed 08/14

  • CVI Investments

    5% stakeDraganfly

    4.9% stake

    Filed 08/14

  • CVI Investments

    5% stakeCervoMed

    0% stake

    Filed 08/14